ACTA1 and systemic sclerosis: It is important that PLG nanoparticles robustly downregulated α-SMA production in fibroblasts isolated from patients with SSc, whereas those from healthy control individuals were only mildly affected, suggesting a disease-specific modification instead of interference in normal wound healing.